The free stock recommendation 'CIS (222080)' has been continuously rising.
Congratulations to all the free members who received the recommendation~! A sell signal is expected soon, so please wait calmly~!!
This stock, operating in the bio industry, has recently started a bio big data construction project.
This project generates data through next-generation analysis technology based on sample biological information from Koreans.
Additionally, there is a supply contract for COVID-19 diagnostic kits in the Middle East! Although it is naturally highly valued, it is still positioned at a low point.
The company was selected for this pilot project due to “over 15 years of genome analysis and research experience and recognized results from data.”
They stated, “We will lay the foundation for building Korean bio big data, which will be key to realizing future precision medicine, and strengthen industrial competitiveness.”
Plans to supply 10 million COVID-19 diagnostic kits to the Middle East... “First supply contract announced, with monthly orders of 2 to 3 million units planned.”
Don’t give up! Become the protagonist of the profit legend with us! You can do it!
“I realized how to make money and how to invest without losing. I just keep being thankful. That’s all I can say.”
(VIP Seo Minjae member / 34 years old)
[Profit status by stock]
Doosan Heavy Industries +142% profit!
KEPCO Engineering & Construction +151% profit!
Bioneer +169% profit!
Madfactor +308% profit!
ATECTN +130% profit!
Sang-A Frontec +121% profit and many other stocks realizing profits!
[Today's stocks of interest]: VIDI / Jindo / NP / InscoBio / Devsisters
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
